Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE MIDDLE EAST AND AFRICA (MEA)TRAUMA DEVICES MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 MIDDLE EAST AND AFRICA (MEA)TRAUMA DEVICES MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 COST ANALYSIS BREAKDOWN
8 TECHNONLOGY ROADMAP
9 INNOVATION TRACKER AND STRATEGIC ANALYSIS
9.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
9.1.1 JOINT VENTURES
9.1.2 MERGERS AND ACQUISITIONS
9.1.3 LICENSING AND PARTNERSHIP
9.1.4 TECHNOLOGY COLLABORATIONS
9.1.5 STRATEGIC DIVESTMENTS
9.2 NUMBER OF PRODUCTS IN DEVELOPMENT
9.3 STAGE OF DEVELOPMENT
9.4 TIMELINES AND MILESTONES
9.5 INNOVATION STRATEGIES AND METHODOLOGIES
9.6 RISK ASSESSMENT AND MITIGATION
9.7 FUTURE OUTLOOK
10 REGULATORY COMPLIANCE
10.1 REGULATORY AUTHORITIES
10.2 REGULATORY CLASSIFICATIONS
10.3 REGULATORY SUBMISSIONS
10.4 INTERNATIONAL HARMONIZATION
10.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
10.6 REGULATORY CHALLENGES AND STRATEGIES
11 REIMBURSEMENT FRAMEWORK
12 VALUE CHAIN ANALYSIS
13 HEALTHCARE ECONOMY
13.1 HEALTHCARE EXPENDITURE
13.2 CAPITAL EXPENDITURE
13.3 CAPEX TRENDS
13.4 CAPEX ALLOCATION
13.5 FUNDING SOURCES
13.6 INDUSTRY BENCHMARKS
13.7 GDP RATION IN OVERALL GDP
13.8 HEALTHCARE SYSTEM STRUCTURE
13.9 GOVERNMENT POLICIES
13.1 ECONOMIC DEVELOPMENT
14 MIDDLE EAST AND AFRICA (MEA)TRAUMA DEVICES MARKET, BY PRODUCT TYPE
14.1 OVERVIEW
NOTE: MARKET VALUE, VOLUME AND ASP ANALYSIS WOULD BE PROVIDED FOR ALL SEGMENTS AND SUB-SEGMENTS OF PRODUCT)
14.2 CORE TRAUMA DEVICES
14.2.1 INTERNAL FIXATOR DEVICES
14.2.1.1. SCREW
14.2.1.1.1. BY TYPE
14.2.1.1.1.1 COMPRESSION BONE SCREWS
14.2.1.1.1.1.1. MARKET VALUE (USD MILLION)
14.2.1.1.1.1.2. MARKET VOLUME (UNITS)
14.2.1.1.1.1.3. AVERAGE SELLING PRICE (USD)
14.2.1.1.1.2 ARTHRODESIS SCREWS
14.2.1.1.1.2.1. MARKET VALUE (USD MILLION)
14.2.1.1.1.2.2. MARKET VOLUME (UNITS)
14.2.1.1.1.2.3. AVERAGE SELLING PRICE (USD)
14.2.1.1.1.3 BONE SCREW WASHERS
14.2.1.1.1.3.1. MARKET VALUE (USD MILLION)
14.2.1.1.1.3.2. MARKET VOLUME (UNITS)
14.2.1.1.1.3.3. AVERAGE SELLING PRICE (USD)
14.2.1.1.2. BY LENGTH
14.2.1.1.2.1 1.5 MM
14.2.1.1.2.2 2 MM
14.2.1.1.2.3 2.7 MM
14.2.1.1.2.4 3.5 MM
14.2.1.1.2.5 OTHERS
14.2.1.1.3. BY MATERIAL
14.2.1.1.3.1 BIOABSORBABLE SCREWS
14.2.1.1.3.2 NON- BIOABSORBABLE SCREWS
14.2.1.1.4. OTHERS
14.2.1.2. NAILING
14.2.1.2.1. TIBIA NAILING SYSTEM
14.2.1.2.1.1 MARKET VALUE (USD MILLION)
14.2.1.2.1.2 MARKET VOLUME (UNITS)
14.2.1.2.1.3 AVERAGE SELLING PRICE (USD)
14.2.1.2.2. FEMUR NAILING SYSTEM
14.2.1.2.2.1 MARKET VALUE (USD MILLION)
14.2.1.2.2.2 MARKET VOLUME (UNITS)
14.2.1.2.2.3 AVERAGE SELLING PRICE (USD)
14.2.1.2.3. OTHERS
14.2.1.2.3.1 MARKET VALUE (USD MILLION)
14.2.1.2.3.2 MARKET VOLUME (UNITS)
14.2.1.2.3.3 AVERAGE SELLING PRICE (USD)
14.2.1.3. PLATES
14.2.1.3.1. COMPRESSION PLATES
14.2.1.3.1.1 MARKET VALUE (USD MILLION)
14.2.1.3.1.2 MARKET VOLUME (UNITS)
14.2.1.3.1.3 AVERAGE SELLING PRICE (USD)
14.2.1.3.2. OSTEOTOMY PLATES
14.2.1.3.2.1 MARKET VALUE (USD MILLION)
14.2.1.3.2.2 MARKET VOLUME (UNITS)
14.2.1.3.2.3 AVERAGE SELLING PRICE (USD)
14.2.1.3.3. ARTHRODESIS PLATES
14.2.1.3.3.1 MARKET VALUE (USD MILLION)
14.2.1.3.3.2 MARKET VOLUME (UNITS)
14.2.1.3.3.3 AVERAGE SELLING PRICE (USD)
14.2.1.3.4. OTHERS
14.2.1.4. STAPLES
14.2.1.4.1. MARKET VALUE (USD MILLION)
14.2.1.4.2. MARKET VOLUME (UNITS)
14.2.1.4.3. AVERAGE SELLING PRICE (USD)
14.2.1.5. WIRES
14.2.1.5.1. MARKET VALUE (USD MILLION)
14.2.1.5.2. MARKET VOLUME (UNITS)
14.2.1.5.3. AVERAGE SELLING PRICE (USD)
14.2.1.6. RODS & PINS
14.2.1.6.1. MARKET VALUE (USD MILLION)
14.2.1.6.2. MARKET VOLUME (UNITS)
14.2.1.6.3. AVERAGE SELLING PRICE (USD)
14.2.1.7. OTHERS
14.2.2 EXTERNAL FIXATOR DEVICES
14.2.2.1. UNILATERAL & BILATERAL EXTERNAL FIXATORS
14.2.2.1.1. MARKET VALUE (USD MILLION)
14.2.2.1.2. MARKET VOLUME (UNITS)
14.2.2.1.3. AVERAGE SELLING PRICE (USD)
14.2.2.2. CIRCULAR FIXATORS
14.2.2.2.1. MARKET VALUE (USD MILLION)
14.2.2.2.2. MARKET VOLUME (UNITS)
14.2.2.2.3. AVERAGE SELLING PRICE (USD)
14.2.2.3. HYBRID FIXATORS
14.2.2.3.1. MARKET VALUE (USD MILLION)
14.2.2.3.2. MARKET VOLUME (UNITS)
14.2.2.3.3. AVERAGE SELLING PRICE (USD)
14.2.2.3.4. OTHERS
14.2.3 INTRAOSSEOUS DEVICES
14.2.3.1. MANUAL
14.2.3.1.1. MARKET VALUE (USD MILLION)
14.2.3.1.2. MARKET VOLUME (UNITS)
14.2.3.1.3. AVERAGE SELLING PRICE (USD)
14.2.3.2. SEMI-AUTOMATED
14.2.3.2.1. MARKET VALUE (USD MILLION)
14.2.3.2.2. MARKET VOLUME (UNITS)
14.2.3.2.3. AVERAGE SELLING PRICE (USD)
14.2.3.3. AUTOMATED
14.2.3.3.1. MARKET VALUE (USD MILLION)
14.2.3.3.2. MARKET VOLUME (UNITS)
14.2.3.3.3. AVERAGE SELLING PRICE (USD)
14.3 SHOULDER ARTHROPLASTY DEVICES
14.3.1 BY TYPE
14.3.1.1. SHOULDER ARTHROPLASTY RESURFACING IMPLANTS
14.3.1.1.1. RESURFACING HEAD
14.3.1.1.1.1 MARKET VALUE (USD MILLION)
14.3.1.1.1.2 MARKET VOLUME (UNITS)
14.3.1.1.1.3 AVERAGE SELLING PRICE (USD)
14.3.1.1.2. SHOULDER CUP
14.3.1.1.2.1 MARKET VALUE (USD MILLION)
14.3.1.1.2.2 MARKET VOLUME (UNITS)
14.3.1.1.2.3 AVERAGE SELLING PRICE (USD)
14.3.1.1.3. HUMERAL STEM
14.3.1.1.3.1 MARKET VALUE (USD MILLION)
14.3.1.1.3.2 MARKET VOLUME (UNITS)
14.3.1.1.3.3 AVERAGE SELLING PRICE (USD)
14.3.1.1.4. ECCENTER
14.3.1.1.4.1 MARKET VALUE (USD MILLION)
14.3.1.1.4.2 MARKET VOLUME (UNITS)
14.3.1.1.4.3 AVERAGE SELLING PRICE (USD)
14.3.1.1.5. GLENOID
14.3.1.1.5.1 MARKET VALUE (USD MILLION)
14.3.1.1.5.2 MARKET VOLUME (UNITS)
14.3.1.1.5.3 AVERAGE SELLING PRICE (USD)
14.3.1.1.6. SHELL SCREWS
14.3.1.1.6.1 MARKET VALUE (USD MILLION)
14.3.1.1.6.2 MARKET VOLUME (UNITS)
14.3.1.1.6.3 AVERAGE SELLING PRICE (USD)
14.3.1.1.7. OTHER
14.3.1.2. SHOULDER ARTHROPLASTY TRAUMA DEVICES
14.3.1.2.1. STEM INSTRUMENTS
14.3.1.2.1.1 MARKET VALUE (USD MILLION)
14.3.1.2.1.2 MARKET VOLUME (UNITS)
14.3.1.2.1.3 AVERAGE SELLING PRICE (USD)
14.3.1.2.2. PRESS INSTRUMENTS
14.3.1.2.2.1 MARKET VALUE (USD MILLION)
14.3.1.2.2.2 MARKET VOLUME (UNITS)
14.3.1.2.2.3 AVERAGE SELLING PRICE (USD)
14.3.1.2.3. GLENOID INSERTION INSTRUMENTS
14.3.1.2.3.1 MARKET VALUE (USD MILLION)
14.3.1.2.3.2 MARKET VOLUME (UNITS)
14.3.1.2.3.3 AVERAGE SELLING PRICE (USD)
14.3.1.2.4. OTHER
14.3.1.3. SHOULDER ARTHROPLASTY PLATFORM SYSTEMS
14.3.2 BY PROCEDURE
14.3.2.1. PARTIAL SHOULDER ARTHROPLASTY
14.3.2.1.1. PARTIAL RESURFACING
14.3.2.1.2. HEMI RESURFACING
14.3.2.1.3. PARTIAL-MID HEAD
14.3.2.1.4. STEMMED HEMI
14.3.2.2. TOTAL SHOULDER ARTHROPLASTY
14.3.2.2.1. TOTAL-MID HEAD
14.3.2.2.2. TOTAL CONVENTIONAL
14.3.2.2.3. TOTAL REVERSE
14.3.2.3. REVIION SHOULDER ARTHROPLASTY
14.4 FOOT AND ANKLE ARTHROPLASTY DEVICES
14.4.1 INTERANL FIXATION DEVICES
14.4.1.1. PLATES
14.4.1.1.1. MARKET VALUE (USD MILLION)
14.4.1.1.2. MARKET VOLUME (UNITS)
14.4.1.1.3. AVERAGE SELLING PRICE (USD)
14.4.1.2. SCREW
14.4.1.2.1. MARKET VALUE (USD MILLION)
14.4.1.2.2. MARKET VOLUME (UNITS)
14.4.1.2.3. AVERAGE SELLING PRICE (USD)
14.4.1.3. FUSION NAILS
14.4.1.3.1. MARKET VALUE (USD MILLION)
14.4.1.3.2. MARKET VOLUME (UNITS)
14.4.1.3.3. AVERAGE SELLING PRICE (USD)
14.4.1.4. WIRE & PINS
14.4.1.4.1. MARKET VALUE (USD MILLION)
14.4.1.4.2. MARKET VOLUME (UNITS)
14.4.1.4.3. AVERAGE SELLING PRICE (USD)
14.4.1.5. INTRAMEDULLARY IMPLANT
14.4.1.5.1. MARKET VALUE (USD MILLION)
14.4.1.5.2. MARKET VOLUME (UNITS)
14.4.1.5.3. AVERAGE SELLING PRICE (USD)
14.4.1.6. HAMMERTOE FIXATION SYSTEM
14.4.1.6.1. MARKET VALUE (USD MILLION)
14.4.1.6.2. MARKET VOLUME (UNITS)
14.4.1.6.3. AVERAGE SELLING PRICE (USD)
14.4.1.7. STAPLE FIXATION SYSTEM
14.4.1.7.1. MARKET VALUE (USD MILLION)
14.4.1.7.2. MARKET VOLUME (UNITS)
14.4.1.7.3. AVERAGE SELLING PRICE (USD)
14.4.1.8. OTHER
14.4.2 EXTERNAL FIXATION DEVICES
14.4.2.1. RING ANKLE FIXATORS
14.4.2.1.1. MARKET VALUE (USD MILLION)
14.4.2.1.2. MARKET VOLUME (UNITS)
14.4.2.1.3. AVERAGE SELLING PRICE (USD)
14.4.2.2. UNILATERAL FIXATORS
14.4.2.2.1. MARKET VALUE (USD MILLION)
14.4.2.2.2. MARKET VOLUME (UNITS)
14.4.2.2.3. AVERAGE SELLING PRICE (USD)
14.4.2.3. HYBRID FIXATORS
14.4.2.3.1. MARKET VALUE (USD MILLION)
14.4.2.3.2. MARKET VOLUME (UNITS)
14.4.2.3.3. AVERAGE SELLING PRICE (USD)
14.4.2.4. OTEHR
14.4.3 JOINT IMPLANT
14.4.3.1. ANKLE IMPLANT
14.4.3.1.1. MARKET VALUE (USD MILLION)
14.4.3.1.2. MARKET VOLUME (UNITS)
14.4.3.1.3. AVERAGE SELLING PRICE (USD)
14.4.3.2. SUBTALAR JOINT IMPLANT
14.4.3.2.1. MARKET VALUE (USD MILLION)
14.4.3.2.2. MARKET VOLUME (UNITS)
14.4.3.2.3. AVERAGE SELLING PRICE (USD)
14.4.3.3. PHALANGEAL IMPLANTS
14.4.3.3.1. MARKET VALUE (USD MILLION)
14.4.3.3.2. MARKET VOLUME (UNITS)
14.4.3.3.3. AVERAGE SELLING PRICE (USD)
14.4.3.4. OTHER
14.4.4 PROSTHESES
14.4.4.1. SOLID ANKLE CUSHION HEEL PROSTHESES
14.4.4.1.1. MARKET VALUE (USD MILLION)
14.4.4.1.2. MARKET VOLUME (UNITS)
14.4.4.1.3. AVERAGE SELLING PRICE (USD)
14.4.4.2. SINGLE ANKLE PROSTHESES
14.4.4.2.1. MARKET VALUE (USD MILLION)
14.4.4.2.2. MARKET VOLUME (UNITS)
14.4.4.2.3. AVERAGE SELLING PRICE (USD)
14.4.4.3. MULTIAXIAL PROSTHESES
14.4.4.3.1. MARKET VALUE (USD MILLION)
14.4.4.3.2. MARKET VOLUME (UNITS)
14.4.4.3.3. AVERAGE SELLING PRICE (USD)
14.4.4.4. DYNAMIC RESPONSE ENERGY STORING PROSTHESES
14.4.4.4.1. MARKET VALUE (USD MILLION)
14.4.4.4.2. MARKET VOLUME (UNITS)
14.4.4.4.3. AVERAGE SELLING PRICE (USD)
14.4.4.5. MICROPROCESSOR CONTROLLED PROSTHESES
14.5 BIOLOGICS
14.5.1 BONE GRFTS
14.5.1.1. ALLOGRAFT
14.5.1.1.1. DEMINERALIZED BONE MATRIX
14.5.1.1.1.1 MARKET VALUE (USD MILLION)
14.5.1.1.1.2 MARKET VOLUME (UNITS)
14.5.1.1.1.3 AVERAGE SELLING PRICE (USD)
14.5.1.1.2. VIABLE BONE MATRIX
14.5.1.1.2.1 MARKET VALUE (USD MILLION)
14.5.1.1.2.2 MARKET VOLUME (UNITS)
14.5.1.1.2.3 AVERAGE SELLING PRICE (USD)
14.5.1.1.3. OTHER
14.5.1.2. SYNTHETIC
14.5.1.2.1. CERAMICS
14.5.1.2.1.1 HAP
14.5.1.2.1.1.1. MARKET VALUE (USD MILLION)
14.5.1.2.1.1.2. MARKET VOLUME (UNITS)
14.5.1.2.1.1.3. AVERAGE SELLING PRICE (USD)
14.5.1.2.1.2 Β-TCP
14.5.1.2.1.2.1. MARKET VALUE (USD MILLION)
14.5.1.2.1.2.2. MARKET VOLUME (UNITS)
14.5.1.2.1.2.3. AVERAGE SELLING PRICE (USD)
14.5.1.2.1.3 Α-TCP
14.5.1.2.1.3.1. MARKET VALUE (USD MILLION)
14.5.1.2.1.3.2. MARKET VOLUME (UNITS)
14.5.1.2.1.3.3. AVERAGE SELLING PRICE (USD)
14.5.1.2.1.4 BI-PHASIC CALCIUM PHOSPHATES (BCP)
14.5.1.2.1.4.1. MARKET VALUE (USD MILLION)
14.5.1.2.1.4.2. MARKET VOLUME (UNITS)
14.5.1.2.1.4.3. AVERAGE SELLING PRICE (USD)
14.5.1.2.1.5 OTHERS
14.5.1.2.2. COMPOSITES
14.5.1.2.2.1 MARKET VALUE (USD MILLION)
14.5.1.2.2.2 MARKET VOLUME (UNITS)
14.5.1.2.2.3 AVERAGE SELLING PRICE (USD)
14.5.1.2.3. POLYMERS
14.5.1.2.3.1 MARKET VALUE (USD MILLION)
14.5.1.2.3.2 MARKET VOLUME (UNITS)
14.5.1.2.3.3 AVERAGE SELLING PRICE (USD)
14.5.1.2.4. BONE MORPHOGENIC PROTEINS (BMP)
14.5.1.2.4.1 MARKET VALUE (USD MILLION)
14.5.1.2.4.2 MARKET VOLUME (UNITS)
14.5.1.2.4.3 AVERAGE SELLING PRICE (USD)
14.5.1.2.5. OTHER
14.5.2 ACELLULAR DERMAL MATRIX
14.5.2.1. MARKET VALUE (USD MILLION)
14.5.2.2. MARKET VOLUME (UNITS)
14.5.2.3. AVERAGE SELLING PRICE (USD)
14.5.3 ALLOGRAFT BONE WEDGE
14.5.3.1. UNICORTAL
14.5.3.1.1. MARKET VALUE (USD MILLION)
14.5.3.1.2. MARKET VOLUME (UNITS)
14.5.3.1.3. AVERAGE SELLING PRICE (USD)
14.5.3.2. TRICORTAL
14.5.3.2.1. MARKET VALUE (USD MILLION)
14.5.3.2.2. MARKET VOLUME (UNITS)
14.5.3.2.3. AVERAGE SELLING PRICE (USD)
14.5.4 NERVE CONDUIT & WRAPS
14.5.4.1. MARKET VALUE (USD MILLION)
14.5.4.2. MARKET VOLUME (UNITS)
14.5.4.3. AVERAGE SELLING PRICE (USD)
14.5.5 SHAFT
14.5.5.1. MARKET VALUE (USD MILLION)
14.5.5.2. MARKET VOLUME (UNITS)
14.5.5.3. AVERAGE SELLING PRICE (USD)
14.5.6 CHIPS
14.5.6.1. MARKET VALUE (USD MILLION)
14.5.6.2. MARKET VOLUME (UNITS)
14.5.6.3. AVERAGE SELLING PRICE (USD)
14.5.7 OTHER
14.6 OTHER
14.6.1 BONE ADHESIVES
14.6.1.1. BONE CEMENT
14.6.1.1.1. BY TYPE
14.6.1.1.1.1 POLYMETHYL METHACRYLATE (PMMA) CEMENT
14.6.1.1.1.1.1. MARKET VALUE (USD MILLION)
14.6.1.1.1.1.2. MARKET VOLUME (UNITS)
14.6.1.1.1.1.3. AVERAGE SELLING PRICE (USD)
14.6.1.1.1.2 CALCIUM PHOSPHATE CEMENT (CPC)
14.6.1.1.1.2.1. MARKET VALUE (USD MILLION)
14.6.1.1.1.2.2. MARKET VOLUME (UNITS)
14.6.1.1.1.2.3. AVERAGE SELLING PRICE (USD)
14.6.1.1.1.3 GLASS POLYALKENOATE CEMENT (GPC)
14.6.1.1.1.3.1. MARKET VALUE (USD MILLION)
14.6.1.1.1.3.2. MARKET VOLUME (UNITS)
14.6.1.1.1.3.3. AVERAGE SELLING PRICE (USD)
14.6.1.1.1.4 OTHERS
14.6.1.1.2. BY LOADING
14.6.1.1.2.1 ANTIBIOTIC-LOADED BONE CEMENT
14.6.1.1.2.2 NON-ANTIBIOTIC-LOADED BONE CEMENT
14.6.1.2. BONE GLUE
14.6.1.2.1. NATURAL BONE GLUE
14.6.1.2.1.1 MARKET VALUE (USD MILLION)
14.6.1.2.1.2 MARKET VOLUME (UNITS)
14.6.1.2.1.3 AVERAGE SELLING PRICE (USD)
14.6.1.2.2. SYNTHETIC BONE GLUE
14.6.1.2.2.1 MARKET VALUE (USD MILLION)
14.6.1.2.2.2 MARKET VOLUME (UNITS)
14.6.1.2.2.3 AVERAGE SELLING PRICE (USD)
15 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY MATERIAL
15.1 OVERVIEW
15.2 BIO-ABSORBABLE
15.2.1 OLYLACTIC ACID POLYMER
15.2.2 POLYGLYCOLIC ACID POLYMERS
15.2.3 OTHERS
15.3 NON- ABSORBABLE
15.3.1 TITANIUM
15.3.2 STAINLESS STEEL
15.3.3 OTHERS
16 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY SURGICAL SITE
16.1 OVERVIEW
16.2 UPPER EXTRIMITIES
16.2.1 SHOULDER
16.2.2 HAND AND WRIST
16.2.3 MAXILLOFACIAL
16.2.4 ELBOW
16.2.5 ARM
16.2.6 OTHERS
16.3 LOWER EXTREMETIES
16.3.1 HIP
16.3.2 THIGH
16.3.3 KNEE
16.3.4 LEG
16.3.5 ANKLE
16.3.6 FOOT
16.3.7 OTHERS
17 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY TRAUMA TYPE
17.1 OVERVIEW
17.2 DISLOCATIONS
17.3 JOINT REPLACEMENT AND FRACTURES
17.4 NERVE DISEASES AND SOFT TISSUE INJURIES
17.5 OTHERS
18 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY PATIENT TYPE
18.1 OVERVIEW
18.2 PEDIATRIC
18.2.1 MALE
18.2.2 FEMALE
18.3 ADULT
18.3.1 MALE
18.3.2 FEMALE
18.4 GERIATRIC
18.4.1 MALE
18.4.2 FEMALE
19 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY END USER
19.1 OVERVIEW
19.2 HOSPITALS
19.2.1 BY TYPE
19.2.1.1. PUBLIC
19.2.1.2. PRIVATE
19.2.2 BY TIER
19.2.2.1. TIER 1
19.2.2.2. TIER 2
19.2.2.3. TIER 3
19.3 TRAUMA CENTRES
19.4 AMBULATORY SURGICAL CENTRES
19.5 SPECIALITY CLINICS
19.6 OTHER
20 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY DISTRIBUTION CHANNEL
20.1 OVERVIEW
20.2 DIRECT TENDERS
20.3 RETAIL SALES
20.3.1 ONLINE SALES
20.3.2 OFFLINE SALES
20.4 OTHERS
21 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, SWOT AND DBMR ANALYSIS
22 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, COMPANY LANDSCAPE
22.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)
22.2 MERGERS & ACQUISITIONS
22.3 NEW PRODUCT DEVELOPMENT & APPROVALS
22.4 EXPANSIONS
22.5 REGULATORY CHANGES
22.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
23 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, BY REGION
MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
23.1 MIDDLE EAST AND AFRICA
23.1.1 SOUTH AFRICA
23.1.2 EGYPT
23.1.3 BAHRAIN
23.1.4 UNITED ARAB EMIRATES
23.1.5 KUWAIT
23.1.6 OMAN
23.1.7 QATAR
23.1.8 SAUDI ARABIA
23.1.9 REST OF MEA
23.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
24 MIDDLE EAST AND AFRICA (MEA) TRAUMA DEVICES MARKET MARKET, COMPANY PROFILE
24.1 GLOBAL COMPANIES
24.1.1 STRYKER
24.1.1.1. COMPANY OVERVIEW
24.1.1.2. REVENUE ANALYSIS
24.1.1.3. GEOGRAPHIC PRESENCE
24.1.1.4. PRODUCT PORTFOLIO
24.1.1.5. RECENT DEVELOPMENTS
24.1.2 DEPUY SYNTHES(JOHNSON & JOHNSON)
24.1.2.1. COMPANY OVERVIEW
24.1.2.2. REVENUE ANALYSIS
24.1.2.3. GEOGRAPHIC PRESENCE
24.1.2.4. PRODUCT PORTFOLIO
24.1.2.5. RECENT DEVELOPMENTS
24.1.3 ZIMMER BIOMET
24.1.3.1. COMPANY OVERVIEW
24.1.3.2. REVENUE ANALYSIS
24.1.3.3. GEOGRAPHIC PRESENCE
24.1.3.4. PRODUCT PORTFOLIO
24.1.3.5. RECENT DEVELOPMENTS
24.1.4 MEDTRONICS
24.1.4.1. COMPANY OVERVIEW
24.1.4.2. REVENUE ANALYSIS
24.1.4.3. GEOGRAPHIC PRESENCE
24.1.4.4. PRODUCT PORTFOLIO
24.1.4.5. RECENT DEVELOPMENTS
24.1.5 ARTHREX, INC
24.1.5.1. COMPANY OVERVIEW
24.1.5.2. REVENUE ANALYSIS
24.1.5.3. GEOGRAPHIC PRESENCE
24.1.5.4. PRODUCT PORTFOLIO
24.1.5.5. RECENT DEVELOPMENTS
24.1.6 SMITH+NEPHEW
24.1.6.1. COMPANY OVERVIEW
24.1.6.2. REVENUE ANALYSIS
24.1.6.3. GEOGRAPHIC PRESENCE
24.1.6.4. PRODUCT PORTFOLIO
24.1.6.5. RECENT DEVELOPMENTS
24.1.7 GLOBUS MEDICAL
24.1.7.1. COMPANY OVERVIEW
24.1.7.2. REVENUE ANALYSIS
24.1.7.3. GEOGRAPHIC PRESENCE
24.1.7.4. PRODUCT PORTFOLIO
24.1.7.5. RECENT DEVELOPMENTS
24.1.8 ORTHOMED
24.1.8.1. COMPANY OVERVIEW
24.1.8.2. REVENUE ANALYSIS
24.1.8.3. GEOGRAPHIC PRESENCE
24.1.8.4. PRODUCT PORTFOLIO
24.1.8.5. RECENT DEVELOPMENTS
24.1.9 DJO, LLC
24.1.9.1. COMPANY OVERVIEW
24.1.9.2. REVENUE ANALYSIS
24.1.9.3. GEOGRAPHIC PRESENCE
24.1.9.4. PRODUCT PORTFOLIO
24.1.9.5. RECENT DEVELOPMENTS
24.1.10 B. BRAUN SE
24.1.10.1. COMPANY OVERVIEW
24.1.10.2. REVENUE ANALYSIS
24.1.10.3. GEOGRAPHIC PRESENCE
24.1.10.4. PRODUCT PORTFOLIO
24.1.10.5. RECENT DEVELOPMENTS
24.1.11 ZIMED MEDIKAL
24.1.11.1. COMPANY OVERVIEW
24.1.11.2. REVENUE ANALYSIS
24.1.11.3. GEOGRAPHIC PRESENCE
24.1.11.4. PRODUCT PORTFOLIO
24.1.11.5. RECENT DEVELOPMENTS
24.1.12 INTEGRA LIFESCIENCES CORPORATION
24.1.12.1. COMPANY OVERVIEW
24.1.12.2. REVENUE ANALYSIS
24.1.12.3. GEOGRAPHIC PRESENCE
24.1.12.4. PRODUCT PORTFOLIO
24.1.12.5. RECENT DEVELOPMENTS
24.1.13 BIORETEC GMBH
24.1.13.1. COMPANY OVERVIEW
24.1.13.2. REVENUE ANALYSIS
24.1.13.3. GEOGRAPHIC PRESENCE
24.1.13.4. PRODUCT PORTFOLIO
24.1.13.5. RECENT DEVELOPMENTS
24.1.14 ORTHOFIX MEDICAL INC.
24.1.14.1. COMPANY OVERVIEW
24.1.14.2. REVENUE ANALYSIS
24.1.14.3. GEOGRAPHIC PRESENCE
24.1.14.4. PRODUCT PORTFOLIO
24.1.14.5. RECENT DEVELOPMENTS
24.2 LOCAL COMPANIES
24.2.1 RENISHAW PLC.
24.2.1.1. COMPANY OVERVIEW
24.2.1.2. REVENUE ANALYSIS
24.2.1.3. GEOGRAPHIC PRESENCE
24.2.1.4. PRODUCT PORTFOLIO
24.2.1.5. RECENT DEVELOPMENTS
24.2.2 TST
24.2.2.1. COMPANY OVERVIEW
24.2.2.2. REVENUE ANALYSIS
24.2.2.3. GEOGRAPHIC PRESENCE
24.2.2.4. PRODUCT PORTFOLIO
24.2.2.5. RECENT DEVELOPMENTS
24.2.3 SURGIPHARM LIMITED
24.2.3.1. COMPANY OVERVIEW
24.2.3.2. REVENUE ANALYSIS
24.2.3.3. GEOGRAPHIC PRESENCE
24.2.3.4. PRODUCT PORTFOLIO
24.2.3.5. RECENT DEVELOPMENTS
24.2.4 BAIRDMED
24.2.4.1. COMPANY OVERVIEW
24.2.4.2. REVENUE ANALYSIS
24.2.4.3. GEOGRAPHIC PRESENCE
24.2.4.4. PRODUCT PORTFOLIO
24.2.4.5. RECENT DEVELOPMENTS
24.2.5 ORTHO-SOL DEVELOPMENT (PTY) LTD
24.2.5.1. COMPANY OVERVIEW
24.2.5.2. REVENUE ANALYSIS
24.2.5.3. GEOGRAPHIC PRESENCE
24.2.5.4. PRODUCT PORTFOLIO
24.2.5.5. RECENT DEVELOPMENTS
25 REPORTS
26 CONCLUSION
27 QUESTIONNAIRE
28 ABOUT DATA BRIDGE MARKET RESEARCH
